Supplement to reduce radiation side effects in cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests whether an oral supplement called sodium-copper chlorophyllin can reduce long-term side effects from radiation therapy in women with cervical cancer. It is designed for people whose radiation plan delivers a higher dose to the rectum or bladder than usually recommended.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cervical cancer (the squamous or glandular type) that has not spread far and are scheduled for radiation therapy, usually with chemotherapy.
- Your radiation plan gives a higher than usual dose to the rectum or bladder, and you are willing to take an extra oral supplement to help protect these areas.
- You are 18 or older and can swallow tablets.
- Your blood counts, kidney, liver, and blood clotting tests are within acceptable ranges.
- You are not HIV positive, not taking blood thinners, and have not had another cancer or radiation treatment that could interfere.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a supplement called chlorophyllin to see if it can help stop bleeding in the gut caused by past radiation therapy. If you have had such bleeding, taking this supplement might reduce the bleeding and help you feel better.
This trial tests whether taking chlorophyllin can reduce mouth sores caused by total body radiation given before a stem cell transplant. The goal is to make the treatment easier to tolerate.
This study tests whether a different way of giving standard chemoradiation can lower the risk of blood-related side effects (like low blood cell counts) in people with locally advanced cervical cancer, while still controlling the disease.
This trial studies whether taking curcumin (from turmeric) during palliative radiation can improve outcomes for people with advanced cervical cancer. It’s meant for patients who are receiving radiation for symptom relief without chemotherapy.
This trial compares two chemotherapy drugs (cisplatin vs. gemcitabine) given together with radiation therapy for locally advanced cervical cancer. The goal is to see which is more effective and has fewer side effects.
This trial tests a shorter course of radiation therapy (fewer, higher-dose sessions) for women in Uganda with locally advanced cervical cancer. The goal is to see if this approach works as well as or better than standard radiation while reducing treatment time.
Hear when a new Uterine Cervical Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.